Most Read Articles
6 days ago
The choice between nonvitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) for stroke prevention appears to be complex and largely heterogenous across different, countries, a new study has found.
Yesterday
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Elvira Manzano, 2 days ago
Long-term treatment with the interleukin-5 receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.
Pearl Toh, 2 days ago
Emerging evidence is showing that the two major new classes of antidiabetic drugs — SGLT2* inhibitors and GLP-1** receptor agonists (RAs) — not only confer cardiovascular (CV) benefits to patients with type 2 diabetes (T2D), they also delay the loss of kidney function among these patients, potentially providing nephrologists with an additional tool in their armamentarium for managing patients with chronic kidney disease (CKD) in the future.

Lower ADHD in high-IQ children

12 Feb 2018

In children, high IQ appears to improve attention and is associated with lower levels of attention deficit/hyperactivity disorder (ADHD) problems, a recent study has shown.

ADHD and comorbid problems in 2,221 children (mean age 11.1±0.56 years; 50.8 percent female; mean IQ, 97.2±15.0) were assessed using questionnaires administered to the participants, to their parents and to their teachers.

There was a strong and positive linear correlation between all symptom domains of IQ scores and hyperactivity-impulsivity problems. Thus, higher IQ scores were associated with lower levels of attention and hyperactivity-impulsivity problems, according to both teacher and parent ratings.

Externalizing problems were also significantly and linearly correlated with IQ scores, although to a lesser degree. Intelligence and self-reported symptoms showed no significant associations.

In separate logistic regression analyses, parents and teachers identified attention problems as the major contributing factor to impaired performance at school. That is, attention problems negatively predicted extra telephone calls because of problems at schools, progress and performance below own capacity.

In a posthoc analysis, the predictive value of teacher-rated attention problems for child performance below own capacity was significantly stronger in the average to high IQ groups (p<0.001 for IQ scores 70–84, 85–99, 100–114 and 115–129).

This relationship was significant but attenuated for those with IQ scores 55–69 (p=0.02).

“[R]esults indicate that high IQ scores are related to decreased levels of ADHD problems, predominantly in relation to attention problems,” said researchers.

“[A]ttention problems were of all symptom domains the strongest predictor of repeating grades and suspected performance below own capacity,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
The choice between nonvitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) for stroke prevention appears to be complex and largely heterogenous across different, countries, a new study has found.
Yesterday
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Elvira Manzano, 2 days ago
Long-term treatment with the interleukin-5 receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.
Pearl Toh, 2 days ago
Emerging evidence is showing that the two major new classes of antidiabetic drugs — SGLT2* inhibitors and GLP-1** receptor agonists (RAs) — not only confer cardiovascular (CV) benefits to patients with type 2 diabetes (T2D), they also delay the loss of kidney function among these patients, potentially providing nephrologists with an additional tool in their armamentarium for managing patients with chronic kidney disease (CKD) in the future.